Discreedly is a digital platform that facilitates omnichannel engagement between pharmaceutical companies and healthcare providers, enabling real-time access to medical information and tailored content delivery. This platform addresses the inefficiencies of traditional engagement methods, improving the ability of healthcare providers to stay informed and enhance patient outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Pharmaceutical companies face challenges in engaging with healthcare providers (HCPs) effectively due to outdated, analog communication methods. HCPs require efficient access to up-to-date medical information and tailored content to inform their clinical decisions and improve patient outcomes.
Solution
Discreedly offers a digital omnichannel engagement platform designed to connect pharmaceutical companies and HCPs, providing real-time access to medical information and tailored content delivery. The platform streamlines communication, enabling needs-based scientific exchange and facilitating access to on-demand Medical Science Liaisons (MSLs). By providing HCPs with the resources they need, Discreedly aims to improve prescribing practices and enhance patient outcomes. The platform also offers reporting and analytics to optimize engagement strategies.
Target Audience
The primary target audience includes pharmaceutical companies seeking to improve their engagement with healthcare providers, as well as healthcare providers who need efficient access to medical information and resources.
Features
- Web-based and mobile application access for HCPs.
- Centralized data dissemination and tailored content delivery through the "meDISphere" feature.
- Streamlined access to Medical Affairs resources and on-demand MSLs.
- Real-time updates on frequently prescribed medications.
- Reporting and analytics tools for pharmaceutical companies to optimize engagement strategies.